Results 241 to 250 of about 696,518 (307)

β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell Carcinoma

Advanced Science, EarlyView.
β‐adrenergic stimulation enhances anti‐tumor immunity in TP53‐deficient oral squamous cell carcinoma by inducing tumor‐derived secretion of CXCL10, which attracts and activates cytotoxic CD8+ T cells. The findings demonstrate that β‐adrenergic signaling alters tumor–immune interactions via CXCL10‐mediated paracrine activation, revealing a neuro‐immune ...
Frederico O. Gleber‐Netto, Deborah Silverman, Tongxin Xie, Shamima Akhter, Nicole R. Vaughn, Adewale Adebayo, Kala Chand Debnath, Shorook Naara, Shajedul Islam, Erik Knutsen, Emily Lorin Ashkin, Simone Anfossi, Sara Leahey, Patrick Hwu, Sebastien Talbot, Erica K Sloan, Robert Saddawi‐Konefka, Roberto Rangel, Jeffrey N. Myers, George A. Calin, Moran Amit   +20 more
wiley   +1 more source

Prioritized barriers to implementation of personalized immunotherapy for sepsis patients. [PDF]

Implement Sci Commun
Bos N, Swillens JEM, Vandeberg L, Schouten JA, van de Veerdonk FL, Netea MG, Study group ESGBIES, Oerlemans AJM, Hulscher MEJL.   +8 more
europepmc   +1 more source

Predictive Role of Baseline Eosinophil Count in Metastatic Melanoma Treated with Nivolumab and Ipilimumab

EJC Skin Cancer
C. Trojaniello, D. Mallardo, V. Vanella, F. Sparano, M.G. Vitale, E. Simeone, L. Festino, A. Facchini, A.L. Marretta, A. Esposito, M. Ottaviano, A. Lagodin D'Amato, B. Alfano, P.A. Ascierto   +13 more
doaj   +1 more source

Survival Outcomes of First-Line Therapy in De Novo Metastatic Urothelial Carcinoma with Histologic Subtypes: A National Cancer Database Analysis. [PDF]

Cancers (Basel)
Myint ZW, Lei F, Tay E, Huang B.
europepmc   +1 more source

Intravenous immunotherapy with Der p 1-containing nanoparticles alleviates the allergic responses in a murine allergic rhinitis model. [PDF]

Hum Vaccin Immunother
Park YM, Kim H, Kim JA, Lee HJ, Chun YH.
europepmc   +1 more source

Immunotherapy rechallenge after progression in non-small cell lung cancer: A systematic review and network meta-analysis. [PDF]

iScience
Li Y, Zhao J, Chen J, Zhou C, Yan Y, Chen W, Xu Y, Li Y.   +7 more
europepmc   +1 more source

Artificial Intelligence for Predicting Immunotherapy Efficacy in Non-Small Cell Lung Cancer. [PDF]

J Inflamm Res
Cao P, Jia X, Yang Y, Wang X, Zhu J, Li X, Yang Z, Wen Q.   +7 more
europepmc   +1 more source

Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population. [PDF]

Cancer Immunol Immunother
Weber M, von Hammerstein-Equord AF, Weinreich M, Andreas S, Rittmeyer A.   +4 more
europepmc   +1 more source